In Re: Zofran (Ondansetron) Products Liability Lit v.
U.S. Court of Appeals for the First Circuit
In Re: Zofran (Ondansetron) Products Liability Lit v.
Opinion
United States Court of Appeals For the First Circuit
No. 21-1517
IN RE: ZOFRAN (ONDANSETRON) PRODUCTS LIABILITY LITIGATION
HEATHER PERHAM, et al.,
Plaintiffs, Appellants,
v.
GLAXOSMITHKLINE LLC,
Defendant, Appellee,
SUN PHARMACEUTICAL INDUSTRIES LTD.; SANDOZ, INC.; PROVIDENCE HEALTH SYSTEM; NOVARTIS PHARMACEUTICALS CORP.; MCKESSON CORPORATION; DOES 1 through 100, inclusive, TEVA PHARMACEUTICAL USA; GLAXOSMITHKLINE HOLDINGS (AMERICAS) INC.,
Defendants.
ERRATA SHEET
The opinion of this Court issued on January 9, 2022, is amended as follows:
On page 3, line 24, "U.S.C.A." is replaced with "U.S.C."
Reference
- Status
- Errata